Beurs gesloten -
Nasdaq
22:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
395,9
USD
|
+1,58%
|
|
+6,43%
|
+29,17%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
3.010
|
4.952
|
7.782
|
6.589
|
9.405
|
12.240
|
-
|
-
|
Bedrijfswaarde
1 |
2.878
|
4.674
|
7.320
|
6.749
|
9.302
|
11.525
|
11.199
|
10.748
|
K/w-verhouding
|
31,5
x
|
36,3
x
|
45,2
x
|
29,2
x
|
34,5
x
|
35,4
x
|
30,2
x
|
25,6
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
3,5
x
|
5,35
x
|
6,81
x
|
4,51
x
|
4,99
x
|
5,64
x
|
4,85
x
|
4,23
x
|
Bedrijfswaarde/omzet
|
3,34
x
|
5,05
x
|
6,41
x
|
4,62
x
|
4,93
x
|
5,31
x
|
4,44
x
|
3,72
x
|
Bedrijfswaarde/EBITDA
|
19,2
x
|
24,9
x
|
32,8
x
|
21,9
x
|
25,7
x
|
26,8
x
|
22,2
x
|
18,4
x
|
Bedrijfswaarde/FCF
|
15,6
x
|
20,6
x
|
31,1
x
|
19,2
x
|
23,4
x
|
24,8
x
|
24
x
|
21,4
x
|
FCF Yield
|
6,39%
|
4,86%
|
3,21%
|
5,2%
|
4,26%
|
4,03%
|
4,17%
|
4,68%
|
Price to Book
|
4,35
x
|
6,51
x
|
8,61
x
|
18,5
x
|
17,5
x
|
13,2
x
|
10,2
x
|
7,92
x
|
Aantal aandelen (in duizenden)
|
35.812
|
35.572
|
35.754
|
31.018
|
30.683
|
30.913
|
-
|
-
|
Referentieprijs
2 |
84,06
|
139,2
|
217,6
|
212,4
|
306,5
|
395,9
|
395,9
|
395,9
|
Datum van publicatie
|
24/02/20
|
15/02/21
|
14/02/22
|
13/02/23
|
12/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
861
|
925,9
|
1.142
|
1.460
|
1.886
|
2.171
|
2.522
|
2.891
|
EBITDA
1 |
149,6
|
187,8
|
223,1
|
308,1
|
362,5
|
430
|
503,8
|
585,6
|
Bedrijfsresultaat (EBIT)
1 |
141,2
|
176,1
|
207,1
|
285,8
|
338,4
|
399,7
|
470,9
|
550,1
|
Operationele Marge
|
16,4%
|
19,02%
|
18,13%
|
19,57%
|
17,94%
|
18,41%
|
18,67%
|
19,03%
|
Resultaat voor belastingen (EBT)
1 |
124,8
|
168,5
|
201,9
|
282,9
|
335,7
|
426
|
500,7
|
586,2
|
Nettowinst (verlies)
1 |
100,4
|
145,4
|
181,8
|
245,4
|
282,8
|
359,9
|
418,5
|
489,9
|
Nettomarge
|
11,67%
|
15,7%
|
15,92%
|
16,81%
|
15%
|
16,57%
|
16,59%
|
16,94%
|
WPA
2 |
2,670
|
3,840
|
4,810
|
7,280
|
8,880
|
11,18
|
13,11
|
15,49
|
Free Cash Flow
1 |
184
|
227,3
|
235,1
|
351,2
|
396,7
|
464,1
|
467,4
|
503,2
|
FCF-marge
|
21,37%
|
24,55%
|
20,58%
|
24,05%
|
21,04%
|
21,37%
|
18,53%
|
17,4%
|
Kasstroomconversie (ebitda)
|
122,97%
|
121,08%
|
105,37%
|
113,98%
|
109,44%
|
107,93%
|
92,77%
|
85,93%
|
Kasstroomconversie (nettowinst)
|
183,14%
|
156,37%
|
129,26%
|
143,12%
|
140,28%
|
128,97%
|
111,67%
|
102,72%
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
24/02/20
|
15/02/21
|
14/02/22
|
13/02/23
|
12/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Omzet
1 |
308,6
|
330,9
|
351,2
|
383,7
|
394,1
|
434,1
|
460,9
|
492,5
|
498,4
|
511
|
528,8
|
554,8
|
572,3
|
594,7
|
619,4
|
EBITDA
1 |
61,41
|
70,38
|
68,09
|
89,26
|
80,37
|
92,85
|
83,63
|
90,18
|
95,84
|
115,7
|
101,1
|
105,9
|
110,2
|
123,2
|
119,7
|
Bedrijfsresultaat (EBIT)
1 |
57,22
|
66,11
|
63,38
|
84,31
|
74,47
|
87,44
|
77,66
|
83,86
|
89,41
|
109
|
94,19
|
99,15
|
102,8
|
113,1
|
112,2
|
Operationele Marge
|
18,55%
|
19,98%
|
18,05%
|
21,97%
|
18,9%
|
20,14%
|
16,85%
|
17,03%
|
17,94%
|
21,33%
|
17,81%
|
17,87%
|
17,96%
|
19,02%
|
18,12%
|
Resultaat voor belastingen (EBT)
1 |
55,92
|
65,32
|
62
|
81,89
|
73,64
|
86,03
|
75,74
|
83,2
|
90,71
|
112,8
|
99,33
|
105,1
|
109,8
|
120,1
|
118,7
|
Nettowinst (verlies)
1 |
50,03
|
61,31
|
49,36
|
66,03
|
68,67
|
72,89
|
61,07
|
70,55
|
78,3
|
102,6
|
81,88
|
86,64
|
90,51
|
100
|
98,93
|
Nettomarge
|
16,22%
|
18,53%
|
14,05%
|
17,21%
|
17,42%
|
16,79%
|
13,25%
|
14,32%
|
15,71%
|
20,07%
|
15,48%
|
15,62%
|
15,81%
|
16,82%
|
15,97%
|
WPA
2 |
1,320
|
1,690
|
1,460
|
2,050
|
2,120
|
2,270
|
1,930
|
2,220
|
2,460
|
3,200
|
2,530
|
2,687
|
2,814
|
3,187
|
3,082
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
14/02/22
|
25/04/22
|
25/07/22
|
24/10/22
|
13/02/23
|
24/04/23
|
24/07/23
|
23/10/23
|
12/02/24
|
22/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
161
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
132
|
278
|
461
|
-
|
103
|
715
|
1.041
|
1.491
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
0,5213
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
184
|
227
|
235
|
351
|
397
|
464
|
467
|
503
|
ROE (netto-inkomsten/eigen vermogen)
|
17,2%
|
19,9%
|
20,7%
|
36,6%
|
59,8%
|
45,7%
|
37,1%
|
35,5%
|
ROA (netto-inkomsten/totale activa)
|
10,7%
|
-
|
11,9%
|
16,3%
|
18,8%
|
18,2%
|
16,5%
|
15,5%
|
Totale activa
1 |
935,7
|
-
|
1.525
|
1.506
|
1.505
|
1.976
|
2.534
|
3.165
|
Nettoactief per aandeel
2 |
19,30
|
21,40
|
25,30
|
11,50
|
17,60
|
30,10
|
38,70
|
50,00
|
Cashflow per aandeel
2 |
5,370
|
6,860
|
6,990
|
11,50
|
13,60
|
16,70
|
15,80
|
18,00
|
Capex
1 |
17,9
|
31,3
|
28,3
|
36,9
|
36,6
|
48,6
|
57
|
63,6
|
Capex/omzet
|
2,08%
|
3,38%
|
2,47%
|
2,53%
|
1,94%
|
2,24%
|
2,26%
|
2,2%
|
Datum van publicatie
|
24/02/20
|
15/02/21
|
14/02/22
|
13/02/23
|
12/02/24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
395,9
USD Gemiddelde koersdoel
425,5
USD Spread / Gemiddelde doel +7,46% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +29,17% | 12,24 mld. | | +1,51% | 42,75 mld. | | +49,22% | 41,61 mld. | | +8,57% | 41,34 mld. | | -12,36% | 26,59 mld. | | +8,92% | 25,49 mld. | | -25,13% | 18,12 mld. | | -3,12% | 11,76 mld. | | +6,35% | 11 mld. | | -16,98% | 10,07 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|